Symbol="CELZ"
AssetType="Common Stock"
Name="Creative Medical Technology Holdings Inc"
Description="Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company is headquartered in Phoenix, Arizona."
CIK="1187953"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="2017 W PEORIA AVENUE, PHOENIX, AZ, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="6766400"
EBITDA="-9511383"
PERatio="None"
PEGRatio="None"
BookValue="9.59"
DividendPerShare="0"
DividendYield="0"
EPS="-6.91"
RevenuePerShareTTM="0.052"
ProfitMargin="0"
OperatingMarginTTM="-130.48"
ReturnOnAssetsTTM="-0.32"
ReturnOnEquityTTM="-0.509"
RevenueTTM="73600"
GrossProfitTTM="39800"
DilutedEPSTTM="-6.91"
QuarterlyEarningsGrowthYOY="3.589"
QuarterlyRevenueGrowthYOY="-0.725"
AnalystTargetPrice="30"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="37.98"
PriceToBookRatio="0.231"
EVToRevenue="39.7"
EVToEBITDA="-1.03"
Beta="5.17"
num_52WeekHigh="14.2"
num_52WeekLow="3.3"
num_50DayMovingAverage="5.09"
num_200DayMovingAverage="5.29"
SharesOutstanding="1430500"
DividendDate="2020-02-03"
ExDividendDate="None"
symbol="CELZ"
open="4.53"
high="4.73"
low="4.49"
price="4.73"
volume="4703.00"
latest_trading_day="2023-08-21"
previous_close="4.52"
change="0.21"
change_percent="4.6460%"
aroon_positive_momentum_days="41"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="41"
Volume_recent_avg="1176868"
Change_recent_avg="-0.01"
Delta_recent_avg="0.25"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-1.12"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="41"
Aroon_momentum_negative="59"
image_negative_thumbnail_id_1="507"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0098.jpeg"
image_negative_thumbnail_id_2="1133"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0166.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="644"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0064.jpeg"
image_positive_thumbnail_id_2="613"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0095.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
